首页    期刊浏览 2024年11月29日 星期五
登录注册

文章基本信息

  • 标题:Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency)
  • 本地全文:下载
  • 作者:Nina Lenherr ; John Christodoulou ; John Duley
  • 期刊名称:Molecular Genetics and Metabolism Reports
  • 印刷版ISSN:2214-4269
  • 出版年度:2021
  • 卷号:26
  • 页码:100709
  • DOI:10.1016/j.ymgmr.2021.100709
  • 出版社:Elsevier B.V.
  • 摘要:Arts syndrome or phosphoribosyl-pyrophosphate-synthetase-1 (PRPS1) deficiency is caused by loss-of-function mutations in the PRPS1 gene (Xq22.3). PRPS1 is an initial and essential step for the synthesis of the nucleotides of purines, pyrimidines, and nicotinamide. Classically, affected males present with sensorineural hearing loss, optic atrophy, muscular hypotonia, developmental impairment, and recurrent severe respiratory infections early in life. Treatment of a 3-year old boy with S-adenosylmethionine (SAM) replenished erythrocyte purine nucleotides of adenosine and guanosine, while SAM and nicotinamide riboside co-therapy further improved his clinical phenotype as well as T-cell survival and function.
  • 关键词:phosphoribosyl-pyrophosphate-synthetase-1 PRPS1 ; 5-phosphoribosyl-1- pyrophosphate PRPP ; PRPP synthase PRPPS ; nicotinamide adenine dinucleotide NAD ; NAD phosphate NADP ; S-adenosylmethionine SAM ; Nicotinamide riboside NR ; Adenosine triphosphate ATP ; Guanosine triphosphate GTP
国家哲学社会科学文献中心版权所有